Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Charité University Medicine Berlin

Status and phase: Unknown; Phase 3; Phase 2

Conditions: Malignancy; Allogeneic Stem Cell Transplantation

Treatments: Drug: Levofloxacin

Study type: Interventional

Funder types: Other

Identifiers

NCT00215007

Levosta-CBF-02/04

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy of levofloxacin to prevent bacterial infections in the postneutropenic period in patients who have undergone allogeneic stem cell transplantation (SCT).

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Allogeneic SCT
• Postneutropenic period
• Written consent

Exclusion criteria

• Fever
• Antibiotic therapy
• Neutropenia
• Refusal by the patient

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind